Stocktoria

AGILENT TECHNOLOGIES, INC. A

NYSE · stock · Laboratory Analytical Instruments · website · IPO 1999-11-18 · LEI

AGILENT TECHNOLOGIES, INC. (A) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 0.73% (safety: safe). FY2025 revenue was $6.9B at a 18.8% net margin.

Chart by TradingView
73/100
Stocktoria Quality Score · grade A
5/9
Piotroski F — financial health
3.48
Altman Z″ — distress risk · safe
0.6%
Dividend yield 5y avg · safe · Dividend payout 21.6%
-2.46
Beneish M-score — earnings quality · low

Quality score trend · recomputed for each fiscal year

Piotroski F /9
2 3 4 3 6 6 6 6 4 5 2016201720182019202020212022202320242025
Altman Z″
6.60 4.27 3.85 2.49 3.02 3.30 3.39 3.90 3.23 3.48 2016201720182019202020212022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$148.24 as of 2026-08-01 · +18% 1y
$113.98$153.5052-wk

Beneish M-score: -2.46 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.

Market cap USD$38.4B
P / E29.5×
Dividend yield 5y avg0.6%
Net margin 5y avg18.8%
Return on equity 5y avg21.7%
Beta1.23
Employees18,000

Analyst price target

$159.32 +7.5% vs last
consensus: buy · 19 analysts
target range $135.00 – $185.00 · median $159.00
4 strong buy · 12 buy · 5 hold
Recent analyst actions
DateFirmRating
2026-08-12Morgan StanleyOverweight (main)
2026-07-06Evercore ISI GroupOutperform (main)
2026-06-24BarclaysOverweight (main)
2026-06-11Piper SandlerNeutral (init)
2026-06-03HSBCBuy (main)
2026-06-02B of A SecuritiesBuy (main)

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Forward estimates · earnings calendar →

Forward EPS est.$6.61
Forward P / E22.4×
Next earnings2026-08-26

Consensus analyst estimates and scheduled dates — forward-looking, may change.

Smart money · insiders, last 12 months

Insiders net sold -$216,672 on the open market · 1 trades

Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.

Revenue trend · last 10y · up

How it ranks in Manufacturing · percentile among 1957 companies

Piotroski Fstronger than 63%
Net marginstronger than 92%
Return on equitystronger than 88%
Revenue growthstronger than 55%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 5/9 tests passed

Altman Z″ components · safe zone

ComponentValue
Working capital / assets0.177
Retained earnings / assets0.109
EBIT / assets0.116
Equity / liabilities1.126

Sector peers · similar-size Manufacturing companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
AAGILENT TECHNOLOGIES, INC.5/93.4829.5+6.7%
AVTRAvantor, Inc.4/91.86-3.4%
ILMNILLUMINA, INC.7/93.0431.4-0.7%
MTDMETTLER TOLEDO INTERNATIONAL INC/5/929.4+4%
BRKRBRUKER CORP4/92.98+2.1%
WATWATERS CORP /DE/4/91055.1+7%
RVTYREVVITY, INC.6/93.8652.3+3.7%

All Manufacturing companies →

About AGILENT TECHNOLOGIES, INC.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

FAQ

Is A financially healthy?

AGILENT TECHNOLOGIES, INC.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.

Does A pay a dividend, and is it safe?

Yes. AGILENT TECHNOLOGIES, INC. pays a dividend yielding about 0.73% with a 21.6% payout ratio, rated “safe” for safety.

How profitable is A?

In FY2025, AGILENT TECHNOLOGIES, INC. had a net margin of 18.8% and a return on equity of 19.3%.

Is A overvalued or undervalued?

AGILENT TECHNOLOGIES, INC. trades at about 32.4× trailing earnings — near its 10-year norm (10-year range 24.0×–74.6×, median 33.6×). Stocktoria reports the data, not buy/sell advice.

What is the analyst price target for A?

The average Wall-Street price target for AGILENT TECHNOLOGIES, INC. is $159.32, about 7.5% above the recent price, from 19 analysts (consensus: buy).

Is A a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on AGILENT TECHNOLOGIES, INC.: a Piotroski F-score of 5/9, an Altman Z″ in the safe zone, a P/E of about 29.5×, a dividend yield of 0.73%. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-10-31. Facts plus Stocktoria's own computed scores — not investment advice.